Theregen, Inc. is a regenerative medicine company that is developing cell-based therapies
for cardiovascular indications. Anginera™, Theregen's lead product, is an epicardial patch designed to improve cardiac function in patients.

What's new?

05/09
Progress in Tissue Engineering (4.7 MB pdf)
Scientific American
 

---